Hypomagnesemia
19
2
2
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
5.3%
1 terminated out of 19 trials
91.7%
+5.1% vs benchmark
32%
6 trials in Phase 3/4
9%
1 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (19)
EffCaMgCit to Prevent Mineral Metabolism and Renal Complications of Chronic PPI Therapy
Association Between Hypomagnesemia and Coagulopathy in Sepsis
Dynamic Magnesium Replacement Strategies and 28-Day Mortality in Non-Cardiac Critically Ill Patients With Hypomagnesemia: A Target Trial Emulation
The Study of Urinary Biomarkers in Patients With Hypomagnesemia
Hypomagnesemia and Its Clinical Outcome
Magnesium Deficiency In Patients Hospitalized in Internal Medicine Wards
Postoperative Incidence of Atrial Fibrillation Following Cardiac Surgery
Intracellular Magnesium and Heart Failure
Averting Complications of Proton Pump Inhibitor Therapy by Effervescent Calcium Magnesium Citrate
Magnesium Replacement and Hyperglycemia After Kidney Transplantation
Hypomagnesemia Associated With Proton-Pump Inhibitor Use
Hypomagnesemia and Hypocalcemia Association Following Thyroidectomy
Feasibility of Using an Integrated Consent Model to Compare Two Standard of Care Regimens for the Management of Hypomagnesemia From Anti-Cancer Therapies
Simplified Regional Citrate Anticoagulation Protocols for CVVH, CVVHDF and SLED: a Pilot Study
Magnesium Supplementation for Hypomagnesemia in Chronic Kidney Disease
Magnesium Replacement Therapy to Prevent Acute Renal Failure in Critically Ill Patients
The Absorption of Magnesium Oxide Compared to Citrate in Healthy Subjects
Magnesium and Metabolic Syndrome
Magnesium to Reduce Implantable Cardioverter Defibrillator (ICD) Shocks and Improve Patient's Quality of Life.